$INCY 3 SEC Filings

Filed On	Filing
06 May 2026	Form 3: Upadhyay Suketu, EVP & Chief Financial Officer No securities owned
03 Dec 2025	Form 3: Hoffman Richard A., EVP & General Counsel No securities owned
24 Sep 2025	Form 3: Gardner David H, EVP, Chief Strategy Officer No securities owned
27 Aug 2025	Form 3: Basi Ramitpal K, EVP, Human Resources No securities owned
05 Aug 2025	Form 3: Mayes Patrick A, EVP & Chief Scientific Officer Holds 67,388 shares of Common Stock
30 Jun 2025	Form 3: Meury William, Director No securities owned
08 Jan 2025	Form 3: Issa Mohamed Khairie, EVP, Head of US Oncology No securities owned
03 Oct 2024	Form 3: Heeson Lee, EVP, Head of Incyte Intl No securities owned
27 Mar 2024	Form 3: Trotta Matteo, EVP, GM, Dermatology US No securities owned
04 Oct 2023	Form 3: Denton Sheila A., EVP & General Counsel No securities owned
07 Jun 2023	Form 3: Cagnoni Pablo J, President, R&D No securities owned
05 Oct 2022	Form 3: Schaffert Susanne, Director No securities owned
23 Mar 2022	Form 3: Tray Thomas, Principal Accounting Officer Holds 3,238 shares of Common Stock
29 Sep 2021	Form 3: Brawley Otis W, Director No securities owned
30 Mar 2020	Form 3: High Katherine A, Director No securities owned
31 Dec 2019	Form 3: Incyte Corp, 10% owner · Merus N.V. Holds 3,200,000 shares of Common Shares, nominal value euro 0.09 per share
19 Dec 2019	Form 3: Harrigan Edmund, Director No securities owned
27 Jun 2019	Form 3: Morrissey Michael James, EVP, Head of Tech. Operations Holds 43,050 shares of Common Stock
27 Jun 2019	Form 3: Dickinson Jonathan Elliott, EVP, General Manager, Europe Holds 24,844 shares of Common Stock
13 Feb 2019	Form 3: Stamoulis Christiana, EVP & Chief Financial Officer No securities owned

Comments